Skip to main content Skip to search Skip to main navigation
Menu
Premium Nahrungsergänzungsmittel | artgerecht

Antiplatelet – Meaning, Mechanism and Clinical Use

Antiplatelet refers to substances or therapies that inhibit the activation and clumping of platelets (thrombocytes), thereby preventing the formation of dangerous blood clots.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "Antiplatelet"

Antiplatelet refers to substances or therapies that inhibit the activation and clumping of platelets (thrombocytes), thereby preventing the formation of dangerous blood clots.

What Does Antiplatelet Mean?

The term antiplatelet describes all substances, medications, or therapies that specifically inhibit the activation and aggregation (clumping) of platelets (thrombocytes). Platelets are small blood components that play an essential role in wound healing but can also contribute to the formation of unwanted blood clots (thrombi), especially within arteries.

Mechanism of Action

Antiplatelet agents target various steps in the platelet activation pathway. The most important mechanisms include:

  • Cyclooxygenase (COX) inhibition: Agents such as acetylsalicylic acid (aspirin) irreversibly block the COX enzyme, preventing the synthesis of thromboxane A2, a potent platelet activator.
  • ADP receptor antagonism (P2Y12 inhibition): Drugs such as clopidogrel, prasugrel, and ticagrelor block the ADP receptor on the platelet surface, preventing platelet activation.
  • Glycoprotein IIb/IIIa receptor antagonism: Agents such as abciximab, tirofiban, and eptifibatide block the final common pathway of platelet aggregation by inhibiting the fibrinogen-binding receptor.
  • Phosphodiesterase inhibition: Drugs such as dipyridamole elevate intracellular cAMP levels, thereby reducing platelet aggregation.

Medical Indications

Antiplatelet therapies are primarily used for the prevention and treatment of arterial thrombosis. Common indications include:

  • Secondary prevention after myocardial infarction (heart attack)
  • Prevention of stroke and transient ischemic attack (TIA)
  • Treatment of coronary artery disease (CAD)
  • After implantation of a coronary artery stent (dual antiplatelet therapy)
  • Peripheral arterial occlusive disease (PAD)

Key Antiplatelet Medications

Acetylsalicylic Acid (Aspirin)

Aspirin is the most widely used antiplatelet agent. At low doses (75–100 mg daily), it permanently inhibits platelet function and is used for long-term prophylaxis of cardiovascular events.

Thienopyridines and Ticagrelor

Clopidogrel, prasugrel, and ticagrelor are frequently combined with aspirin as dual antiplatelet therapy (DAPT), particularly after acute coronary syndrome or stent implantation.

Glycoprotein IIb/IIIa Inhibitors

These agents are primarily administered intravenously in the acute management of myocardial infarction or during high-risk coronary interventions.

Side Effects and Risks

The most significant risk associated with antiplatelet therapy is an increased tendency to bleed. Possible side effects include:

  • Gastrointestinal bleeding (especially with aspirin)
  • Prolonged bleeding time after injuries or surgery
  • Rarely: intracranial hemorrhage
  • Thrombocytopenia (possible with glycoprotein IIb/IIIa inhibitors)

Before any planned surgical procedure, antiplatelet therapy should be adjusted or temporarily discontinued in consultation with the treating physician.

Distinction from Anticoagulation

Antiplatelet agents are distinct from anticoagulants (such as heparin, warfarin, or direct oral anticoagulants). While antiplatelet agents specifically inhibit platelet activation, anticoagulants target the coagulation cascade in plasma. Both types of therapy can be used in combination when clinically indicated.

References

  1. Patrono C. et al. - Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. Journal of the American College of Cardiology, 2017.
  2. Collet J.P. et al. - 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 2021.
  3. Bhatt D.L. - Antiplatelet Therapy: Evidence-Based Practice. In: Harrison's Principles of Internal Medicine, 21st Edition, McGraw Hill.

Most purchased products

natural iron supplement premium plantderived mineralcomplex?ts=1751927698

Average rating of 4.94 out of 5 stars

Natural Iron

For your iron balance

Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Gluten free
Lactose free
100% vegetarian fermentation
30 Capsules
30 Capsules
Regular price: €35.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
lactoferrin kapseln 60 premium eisenbindung immunschutz laktosefrei milch?ts=1751997240

Average rating of 4.85 out of 5 stars

Lactoferrin 60 Capsules

For your universal protection

As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Lactose free
Pure CLN
60 Capsules
60 Capsules
Regular price: €59.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
floral fresh mint kapseln?ts=1726594235

Average rating of 4.96 out of 5 stars

Floral

For Healthy Oral Flora & Dental Care

Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®
Sugar free
Lab tested
Non-GMO
Cologne List
Lactose free
Tooth friendly
GMP Quality
Clinical proofed
Pure CLN
30 lozenges
Regular price: €22.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.

The latest entries

3 Posts in this encyclopedia category

Migraine aura

Migraine aura refers to transient neurological symptoms that occur before or during a migraine attack, lasting between 5 and 60 minutes.

Filoviridae

Filoviridae are a family of filamentous RNA viruses that include the Ebola and Marburg viruses. They cause severe viral hemorrhagic fevers with high fatality rates.

Bundibugyo ebolavirus

Bundibugyo ebolavirus (BDBV) is one of five recognized Ebolavirus species and causes Bundibugyo virus disease, a severe and potentially fatal hemorrhagic fever.

Related search terms: Antiplatelet-en